Term	Overlap	P-value	Adjusted P-value	Old P-value	Old Adjusted P-value	Odds Ratio	Combined Score	Genes
Human Complement System WP2806	9/97	7.132511399317303E-4	0.3366545380477767	0	0	3.718777761708985	26.94506238326173	PRNP;CR1;ITGA2;WAS;SPP1;F13A1;SERPING1;CD59;VSIG4
Serotonin Transporter Activity WP1455	3/11	0.002193714906129018	0.5177167178464482	0	0	10.93095281472035	66.92102971125014	PPP2CB;TPH2;IL1R1
Osteopontin Signaling WP1434	3/13	0.003663762206263562	0.5764319204521338	0	0	9.249267766301834	51.8815914997403	SPP1;MMP9;MAPK3
Cytokines and Inflammatory Response WP530	4/26	0.003701439888212337	0.43676990680905575	0	0	6.16617851086789	34.52463928508319	IL10;IL11;CD4;CSF2
Fatty Acid Omega Oxidation WP206	3/15	0.005616675024640031	0.5302141223260189	0	0	8.016032064128257	41.5392017858638	ALDH2;ALDH1A1;CYP1A1
Chemokine signaling pathway WP3929	10/164	0.00824915910023044	0.6489338492181279	0	0	2.443912214673249	11.72502080032083	CCL22;NCF1;CCL7;GNG4;WAS;ARRB1;CXCL13;GNG12;CCR4;MAPK3
Spinal Cord Injury WP2431	8/118	0.009516833442234777	0.641706483533545	0	0	2.7172990047892394	12.648192947586551	EFNB2;IL1R1;TNFSF13;CCL2;MMP9;FCGR2C;LTB4R;MAPK3
Wnt Signaling Pathway and Pluripotency WP399	7/102	0.013961365514387793	0.8237205653488797	0	0	2.750599237691069	11.749078388739441	PPP2CB;FZD2;MMP7;FZD7;LRRK2;WNT5A;NKD2
TYROBP Causal Network WP3945	5/61	0.017942576223113686	0.9409884419232954	0	0	3.2852590426755146	13.208642959627593	CD4;KCNE3;DPYD;RNASE6;SPP1
Viral Acute Myocarditis WP4298	6/84	0.018533274840186447	0.8747705724568003	0	0	2.86286859433152	11.417656806480785	IL10;DFFB;CD4;TLR5;MMP9;MAPK3
Benzo(a)pyrene metabolism WP696	2/9	0.019912211750142357	0.8544149041879265	0	0	8.90670229347584	34.882405519263955	AKR1C1;CYP1A1
TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036	4/42	0.0202878311040426	0.7979880234256757	0	0	3.81715812577536	14.878267108239372	TNFSF12;CCL2;MMP9;MAPK3
Lung fibrosis WP3624	5/63	0.020365764834761314	0.7394339232313338	0	0	3.1809651048128	12.386359965174886	CSF2;FAM13A;SPP1;CCL2;MMP9
IL1 and megakaryocytes in obesity WP2865	3/24	0.02117313795562006	0.713837222503762	0	0	5.01002004008016	19.313737366186253	IL1R1;CCL2;MMP9
Vitamin A and Carotenoid Metabolism WP716	4/43	0.021940344052406784	0.6903894928490668	0	0	3.728387006571282	14.240306259941201	SULT1A1;RBP7;ALDH1A1;CD36
Tryptophan metabolism WP465	4/46	0.027380120670636623	0.8077135597837803	0	0	3.485231332229677	12.539646429822215	ALDH3A2;ALDH2;ALDH1A1;CYP1A1
Selective expression of chemokine receptors during T-cell polarization WP4494	3/29	0.034896686429043866	0.9688962349711002	0	0	4.14622348144565	13.912086513749546	CD4;CSF2;CCR4
Matrix Metalloproteinases WP129	3/30	0.03807704815856621	0.9984648183801806	0	0	4.008016032064129	13.098771899430595	MMP7;MMP19;MMP9
Development of pulmonary dendritic cells and macrophage subsets WP3892	2/13	0.040402734490517254	1.0	0	0	6.16617851086789	19.78639007798208	SPI1;CSF2
Monoamine Transport WP727	3/32	0.04486378082167966	1.0	0	0	3.7575150300601203	11.663794362384895	TPH2;PPP2CB;IL1R1
MAPK Signaling Pathway WP382	11/246	0.045327883298084744	1.0	0	0	1.7922022907603825	5.544774429440758	DUSP10;IL1R1;LRRK2;CACNA2D3;RRAS2;ARRB1;HSPA2;GNG12;HSPA1B;MAP2K6;MAPK3
Hematopoietic Stem Cell Differentiation WP2849	4/55	0.04815323704518734	1.0	0	0	2.9149207505920933	8.842024163658012	NFE2;CSF2;SPI1;LMO2
IL-1 signaling pathway WP195	4/55	0.04815323704518734	0.9881881689273229	0	0	2.9149207505920933	8.842024163658012	IL1R1;CCL2;MAPK3;MAP2K6
RANKL/RANK (Receptor activator of NFKB (ligand)) Signaling Pathway WP2018	4/55	0.04815323704518734	0.9470136618886844	0	0	2.9149207505920933	8.842024163658012	SPI1;CTSK;MAPK3;MAP2K6
Prion disease pathway WP3995	3/33	0.04846676224858994	0.9150524712533781	0	0	3.6436509382401168	11.028883331885812	PRNP;SPI1;MAPK3
Type 2 papillary renal cell carcinoma WP4241	3/34	0.05220691871825585	0.9477563705775677	0	0	3.536484734174231	10.44161352250808	ARNT2;EPAS1;CTSK
Role of Osx and miRNAs in tooth development WP3971	2/15	0.05264396193280757	0.9202944456401916	0	0	5.344021376085505	15.733887669292315	HNF1A;KLF4
Nuclear Receptors Meta-Pathway WP2882	13/319	0.05794375042186246	0.9767660785399671	0	0	1.6333607654179831	4.652272981231376	IL11;SERPINB2;SLC39A11;MGST2;NRG1;SLC7A11;PTGR1;SLC39A14;SULT1A1;FGD4;MAFG;CYP1A1;CCL2
MicroRNAs in cardiomyocyte hypertrophy WP1544	5/84	0.058935557970097745	0.9592270124788322	0	0	2.3857238286096	6.754725331133143	FZD2;WNT5A;NRG1;MAPK3;MAP2K6
Osteoclast Signaling WP12	2/16	0.059195084025969825	0.9313359886752586	0	0	5.01002004008016	14.162909722655604	CTSK;SPP1
Regulation of toll-like receptor signaling pathway WP1449	7/139	0.059787478106507704	0.9103125698797302	0	0	2.01842533988841	5.685821500021543	BTK;SPP1;TLR8;TLR5;CTNNAL1;MAP2K6;MAPK3
Wnt Signaling in Kidney Disease WP4150	3/36	0.060090063168788566	0.8863284317396314	0	0	3.34001336005344	9.3918196038763	FZD2;FZD7;WNT5A
ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336	5/86	0.06391808525299726	0.9142223102852942	0	0	2.330241879107051	6.40852153921544	FZD2;FZD7;WNT5A;KLF4;NKD2
Regulation of Wnt/B-catenin Signaling by Small Molecule Compounds WP3664	2/17	0.06600916139257469	0.9163624758028016	0	0	4.715312978898974	12.816040257505042	LRP1;FZD7
T-Cell antigen Receptor (TCR) pathway during Staphylococcus aureus infection WP3863	4/62	0.06894563276553183	0.9297811047237435	0	0	2.5858167948800825	6.9156041525630165	IL10;CD4;CSF2;MAPK3
4-hydroxytamoxifen, Dexamethasone, and Retinoic Acids Regulation of p27 Expression WP3879	2/18	0.07306905370565892	0.9580164819186392	0	0	4.45335114673792	11.651526803744126	MAPK3;MAP2K6
Estrogen metabolism WP697	2/18	0.07306905370565892	0.9321241445694868	0	0	4.45335114673792	11.651526803744126	SULT1A1;CYP1A1
Inhibition of exosome biogenesis and secretion by Manumycin A in CRPC cells WP4301	2/18	0.07306905370565892	0.9075945618176582	0	0	4.45335114673792	11.651526803744126	RRAS2;MAPK3
Simplified Depiction of MYD88 Distinct Input-Output Pathway WP3877	2/18	0.07306905370565892	0.8843229063864362	0	0	4.45335114673792	11.651526803744126	TLR8;TLR5
NRF2 pathway WP2884	7/146	0.07358799502840058	0.8683383413351269	0	0	1.9216515222225272	5.014114157918484	MAFG;SLC39A11;MGST2;NRG1;SLC7A11;PTGR1;SLC39A14
Endochondral Ossification WP474	4/64	0.07561155525750367	0.8704549775985789	0	0	2.50501002004008	6.468302004396629	SPP1;CTSV;MMP9;CST5
Ferroptosis WP4313	3/40	0.07739908621583053	0.8698183022350479	0	0	3.006012024048096	7.691724362083672	PRNP;SLC7A11;SLC39A14
Glycogen Synthesis and Degradation WP500	3/40	0.07739908621583053	0.8495899696249304	0	0	3.006012024048096	7.691724362083672	PPP2CB;GSK3A;PYGL
IL-5 Signaling Pathway WP127	3/40	0.07739908621583053	0.8302811066789093	0	0	3.006012024048096	7.691724362083672	GSK3A;BTK;MAPK3
Extracellular vesicles in the crosstalk of cardiac cells WP4300	2/19	0.08035830927595211	0.8428693772944311	0	0	4.2189642442780295	10.637104856576954	SPP1;MMP9
Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433	3/41	0.08203209740102893	0.8417206515931663	0	0	2.9326946576078985	7.333627283603584	NLRP12;CARD9;NLRC4
AGE/RAGE pathway WP2324	4/66	0.08258943168134009	0.8294087607147346	0	0	2.4291006254934113	6.057869806005826	MMP7;NCF1;MMP9;MAPK3
PPAR signaling pathway WP3942	4/67	0.08619314708781191	0.8475659463634838	0	0	2.3928453922770916	5.8652579298637555	FADS2;OLR1;CD36;SLC27A2
Vitamin D Receptor Pathway WP2877	8/182	0.08642602523327252	0.8325119165327475	0	0	1.761765288819397	4.313623168185097	CDKN2D;STEAP4;DUSP10;CYP1A1;SPP1;HNF1A;KLF4;S100A8
Neovascularisation processes WP4331	2/21	0.09556240546555268	0.9021091075948173	0	0	3.81715812577536	8.962594845063215	MMP9;MAPK3
Tamoxifen metabolism WP691	2/21	0.09556240546555268	0.8844206937204092	0	0	3.81715812577536	8.962594845063215	SULT1A1;CYP1A1
Myometrial Relaxation and Contraction Pathways WP289	7/156	0.09629885800151898	0.8740973264753262	0	0	1.7984687323364679	4.208954250308523	IGFBP4;GNG4;PKIA;RGS16;ARRB1;GNG12;DGKZ
Interleukin-11 Signaling Pathway WP2332	3/44	0.09661832954836673	0.8604500291854547	0	0	2.7327382036800874	6.386373134138706	IL11;ITGA2;MAPK3
PI3K/AKT/mTOR - VitD3 Signalling WP4141	2/22	0.10344757711016117	0.904208451777705	0	0	3.6436509382401168	8.266315525388785	IL10;PFKFB4
Ebola Virus Pathway on Host WP4217	6/129	0.10425940272900253	0.894735237965258	0	0	1.864193503285641	4.214705184000139	GSN;CTSL;ITGA2;TYRO3;ASGR1;MAPK3
Toll-like Receptor Signaling Pathway WP75	5/103	0.11529521549174508	0.9717739591447085	0	0	1.9456388505165672	4.203084516094026	SPP1;TLR8;TLR5;MAP2K6;MAPK3
Secretion of Hydrochloric Acid in Parietal Cells WP2597	1/5	0.11868930417379521	0.9828307292987954	0	0	8.016032064128257	17.084136989836733	HRH2
Sulindac Metabolic Pathway WP2542	1/5	0.11868930417379521	0.9658853718970921	0	0	8.016032064128257	17.084136989836733	MSRA
TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer WP2868	1/5	0.11868930417379521	0.9495144333903617	0	0	8.016032064128257	17.084136989836733	MAPK3
Structural Pathway of Interleukin 1 (IL-1) WP2637	3/49	0.12303208395108468	0.9678523937485328	0	0	2.4538873665698744	5.141655014092984	IL1R1;MAPK3;MAP2K6
Circadian rhythm related genes WP3594	8/201	0.13122292542368252	1.0	0	0	1.595230261518061	3.2396856300075423	TPH2;ARNT2;DBP;CREM;ID3;AVP;ADA;HS3ST2
Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932	11/303	0.13859115955840526	1.0	0	0	1.455055325171796	2.8755195882478497	PPP2CB;PFKFB4;EPAS1;GNG4;ITGA2;SPP1;GNG12;MET;PGF;CREB5;MAPK3
Copper homeostasis WP3286	3/52	0.13999992801020142	1.0	0	0	2.3123169415754585	4.546277255863601	PRNP;STEAP4;SLC31A1
Arylamine metabolism WP694	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	SULT1A1
Benzene metabolism WP3891	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	MPO
Thyroxine (Thyroid Hormone) Production WP1981	1/6	0.14068347176921273	1.0	0	0	6.68002672010688	13.101154263168134	TRH
let-7 inhibition of ES cell reprogramming WP3299	1/6	0.14068347176921273	0.9910835623144538	0	0	6.68002672010688	13.101154263168134	KLF4
TGF-beta Receptor Signaling WP560	3/54	0.15172330275644763	1.0	0	0	2.22667557336896	4.19883498917209	BAMBI;SPP1;MAPK3
Cardiac Hypertrophic Response WP2795	3/55	0.1576985010678366	1.0	0	0	2.18619056294407	4.038047637132014	NRG1;MAPK3;MAP2K6
Disorders of the Krebs cycle WP4236	1/7	0.1621298222363275	1.0	0	0	5.72573718866304	10.417165146564741	SUCLG2
EV release from cardiac cells and their functional effects WP3297	1/7	0.1621298222363275	1.0	0	0	5.72573718866304	10.417165146564741	RGS16
MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593	1/7	0.1621298222363275	1.0	0	0	5.72573718866304	10.417165146564741	HEY1
Cannabinoid receptor signaling WP3869	2/29	0.16269376292415	1.0	0	0	2.764148987630433	5.0193783437657435	CYP1A1;MAPK3
MAPK Cascade WP422	2/29	0.16269376292415	1.0	0	0	2.764148987630433	5.0193783437657435	MAPK3;MAP2K6
ESC Pluripotency Pathways WP3931	5/116	0.16446609437382845	1.0	0	0	1.7275931172690209	3.1183934131192865	FZD2;FZD7;WNT5A;HNF1A;MAP2K6
Calcium Regulation in the Cardiac Cell WP536	6/149	0.16937081345091762	1.0	0	0	1.6139661874083737	2.865862955903672	GNG4;PKIA;RGS16;ARRB1;CAMK1;GNG12
Extracellular vesicle-mediated signaling in recipient cells WP2870	2/30	0.17159496050911424	1.0	0	0	2.6720106880427523	4.709735364120289	WNT5A;MET
Complement and Coagulation Cascades WP558	3/58	0.17603867561833744	1.0	0	0	2.073111740722825	3.6011019838025167	CR1;SERPING1;TFPI
Ethanol effects on histone modifications WP3996	2/31	0.18057393039320113	1.0	0	0	2.5858167948800825	4.425922809233922	ALDH2;ALDH1A1
Toll-like Receptor Signaling WP3858	2/31	0.18057393039320113	1.0	0	0	2.5858167948800825	4.425922809233922	TLR8;TLR5
ApoE and miR-146 in inflammation and atherosclerosis WP3926	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	SPI1
Effects of Nitric Oxide WP1995	1/8	0.18304197291732785	1.0	0	0	5.01002004008016	8.507213387954755	MB
Breast cancer pathway WP4262	6/154	0.18783408010595262	1.0	0	0	1.5615646878171927	2.611242628309546	FZD2;HEY1;FZD7;WNT5A;GADD45G;MAPK3
Apoptosis Modulation and Signaling WP1772	4/91	0.19244164904232453	1.0	0	0	1.761765288819397	2.9033227652017337	DFFB;IL1R1;TNFRSF10C;MAPK3
GPCRs, Class A Rhodopsin-like WP455	9/257	0.19452070235475658	1.0	0	0	1.4035853808784886	2.297973401232536	P2RY13;HRH1;GPR15;HRH2;GPR75;NMUR1;CCR4;LTB4R;PTGDR
TNF alpha Signaling Pathway WP231	4/92	0.19754192618224412	1.0	0	0	1.7426156661148384	2.826181811802842	CCL2;PYGL;MAPK3;MAP2K6
Fluoropyrimidine Activity WP1601	2/33	0.19872802219851757	1.0	0	0	2.4291006254934113	3.924984785802817	CDA;DPYD
Monoamine GPCRs WP58	2/33	0.19872802219851757	1.0	0	0	2.4291006254934113	3.924984785802817	HRH1;HRH2
Signal transduction through IL1R WP4496	2/33	0.19872802219851757	1.0	0	0	2.4291006254934113	3.924984785802817	IL1R1;MAP2K6
Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706	6/158	0.20314068811377023	1.0	0	0	1.5220314045813146	2.425899639922339	IL10;TPH2;DLX2;KCNQ1;CREM;AVP
Folate-Alcohol and Cancer Pathway Hypotheses WP1589	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	ALDH1A1
Methylation Pathways WP704	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	HNMT
Pyrimidine metabolism and related diseases WP4225	1/9	0.2034332036105457	1.0	0	0	4.45335114673792	7.091594592595487	DPYD
Epithelial to mesenchymal transition in colorectal cancer WP4239	6/159	0.20703678527436165	1.0	0	0	1.5124588800241994	2.3819091690782233	FZD2;FZD7;WNT5A;MMP9;MAP2K6;MAPK3
LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258	4/94	0.2078634121569063	1.0	0	0	1.705538737048565	2.6791866069280528	FZD2;FZD7;WNT5A;NKD2
Signaling of Hepatocyte Growth Factor Receptor WP313	2/34	0.20788559348521826	1.0	0	0	2.357656489449487	3.703329911410121	MET;MAPK3
G1 to S cell cycle control WP45	3/64	0.2142944279585239	1.0	0	0	1.8787575150300602	2.8940463012915596	CDKN2D;CCNA1;RPA3
Photodynamic therapy-induced NF-kB survival signaling WP3617	2/35	0.21708580634058053	1.0	0	0	2.290294875465216	3.4983397255667774	CSF2;MMP9
Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269	1/10	0.22331646466575467	1.0	0	0	4.008016032064129	6.008678915692337	MAFG
Mammary gland development pathway - Involution (Stage 4 of 4) WP2815	1/10	0.22331646466575467	1.0	0	0	4.008016032064129	6.008678915692337	MMP9
Trans-sulfuration pathway WP2333	1/10	0.22331646466575467	1.0	0	0	4.008016032064129	6.008678915692337	CSAD
Zinc homeostasis WP3529	2/36	0.22632085176125513	1.0	0	0	2.22667557336896	3.308398103918243	SLC39A11;SLC39A14
Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680	3/66	0.2274211998774077	1.0	0	0	1.8218254691200584	2.698035115244598	FZD2;FZD7;CAMK1
Non-small cell lung cancer WP4255	3/66	0.2274211998774077	1.0	0	0	1.8218254691200584	2.698035115244598	RASSF1;MAPK3;GADD45G
Melatonin metabolism and effects WP3298	2/37	0.23558328242720192	1.0	0	0	2.1664951524670966	3.132082082352866	SULT1A1;CYP1A1
miRNAs involvement in the immune response in sepsis WP4329	2/37	0.23558328242720192	1.0	0	0	2.1664951524670966	3.132082082352866	IL10;TLR8
Methionine metabolism leading to Sulphur Amino Acids and related disorders WP4292	1/11	0.24270438526211566	1.0	0	0	3.6436509382401168	5.159085799816664	CSAD
Nucleotide GPCRs WP80	1/11	0.24270438526211566	1.0	0	0	3.6436509382401168	5.159085799816664	LTB4R
SRF and miRs in Smooth Muscle Differentiation and Proliferation WP1991	1/11	0.24270438526211566	1.0	0	0	3.6436509382401168	5.159085799816664	KLF4
Parkinsons Disease Pathway WP2371	2/38	0.2448659994548925	1.0	0	0	2.1094821221390148	2.968134498606979	LRRK2;SNCA
Sleep regulation WP3591	2/38	0.2448659994548925	1.0	0	0	2.1094821221390148	2.968134498606979	ADA;PTGDR
Parkin-Ubiquitin Proteasomal System pathway WP2359	3/70	0.25409344878000956	1.0	0	0	1.7177211565989121	2.353369317565394	HSPA2;HSPA1B;SNCA
Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341	3/71	0.2608321328699177	1.0	0	0	1.6935279008721669	2.2758953077910986	TLR8;CCL2;MAPK3
Bile Acids synthesis and enterohepatic circulation  WP4389	1/12	0.26160928125317606	1.0	0	0	3.34001336005344	4.4786345398527265	MAPK3
IL-10 Anti-inflammatory Signaling Pathway  WP4495	1/12	0.26160928125317606	1.0	0	0	3.34001336005344	4.4786345398527265	IL10
MAPK  and NFkB Signalling Pathways Inhibited by Yersinia YopJ WP3849	1/12	0.26160928125317606	1.0	0	0	3.34001336005344	4.4786345398527265	MAP2K6
Bladder Cancer WP2828	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	RASSF1;MMP9
Microglia Pathogen Phagocytosis Pathway WP3937	2/40	0.26346556444202246	1.0	0	0	2.0040080160320644	2.6730112320046	NCF1;NCF4
Dopamine metabolism WP2436	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	PPP2CB
Estrogen Receptor Pathway WP2881	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	CYP1A1
Genes targeted by miRNAs in adipocytes WP1992	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	KCNQ1
Kennedy pathway from Sphingolipids WP3933	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	CHKB
MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	MAPK3
Purine metabolism WP4224	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	ADA
ncRNAs involved in STAT3 signaling in hepatocellular carcinoma WP4337	1/13	0.28004316287106085	1.0	0	0	3.083089255433945	3.924191566463159	IL11
Fas Ligand (FasL) pathway and Stress induction of Heat Shock Proteins (HSP) regulation WP314	2/42	0.28206925448515735	1.0	0	0	1.90857906288768	2.4155027291038484	DFFB;LMNB1
Cysteine and methionine catabolism WP4504	1/14	0.29801774237092626	1.0	0	0	2.86286859433152	3.4657951791914905	CSAD
Hedgehog Signaling Pathway WP4249	2/44	0.3006315833357493	1.0	0	0	1.8218254691200584	2.1895969020440007	FBXL17;ARRB1
Metapathway biotransformation Phase I and II WP702	6/183	0.30702842518690104	1.0	0	0	1.314103617070206	1.5517131909665904	SULT1A1;AKR1C1;CYP1A1;MGST2;HNMT;HS3ST2
Prostaglandin Synthesis and Regulation WP98	2/45	0.30988425031274364	1.0	0	0	1.7813404586951682	2.0869408814372057	AKR1C1;PTGDR
Ras Signaling WP4223	6/184	0.31139427036755796	1.0	0	0	1.3069617495861288	1.524826286497194	RASSF1;GNG4;RRAS2;GNG12;MET;MAPK3
GPCRs, Class C Metabotropic glutamate, pheromone WP501	1/15	0.31554444134617654	1.0	0	0	2.6720106880427523	3.0820460838194843	GPRC5A
Phytochemical activity on NRF2 transcriptional activation WP3	1/15	0.31554444134617654	1.0	0	0	2.6720106880427523	3.0820460838194843	SLC7A11
Aryl Hydrocarbon Receptor Pathway WP2873	2/46	0.31911152054298275	1.0	0	0	1.7426156661148384	1.990441131153559	SERPINB2;CYP1A1
Aryl Hydrocarbon Receptor WP2586	2/46	0.31911152054298275	1.0	0	0	1.7426156661148384	1.990441131153559	CYP1A1;CD36
Regulation of Actin Cytoskeleton WP51	5/150	0.32014360180599605	1.0	0	0	1.3360053440213762	1.5216908860458618	GSN;WAS;RRAS2;GNG12;MAPK3
Wnt Signaling WP428	4/115	0.3230160532304537	1.0	0	0	1.3940925328918707	1.5753988067831293	FZD2;FZD7;WNT5A;NKD2
Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203	2/47	0.3283089077825412	1.0	0	0	1.705538737048565	1.8996295941430157	BTK;MAPK3
Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	SYTL1
ID signaling pathway WP53	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	ID3
TCA Cycle and Deficiency of Pyruvate Dehydrogenase complex (PDHc) WP2453	1/16	0.33263439792491434	1.0	0	0	2.50501002004008	2.757292826325945	SUCLG2
Signaling Pathways in Glioblastoma WP2261	3/82	0.33589955964487944	1.0	0	0	1.4663473288039492	1.5997014907898262	MET;MAPK3;MAP2K6
Differentiation Pathway WP2848	2/48	0.33747216444826783	1.0	0	0	1.67000668002672	1.814081910119734	IL11;WNT5A
Alzheimers Disease WP2059	3/83	0.34274722112888345	1.0	0	0	1.4486804935171547	1.5511921213225777	LRP1;SNCA;MAPK3
Hepatitis C and Hepatocellular Carcinoma WP3646	2/49	0.3465972728961172	1.0	0	0	1.6359249110465828	1.7334125719038218	HNF1A;MAPK3
Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	EPAS1
IL-9 Signaling Pathway WP22	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	MAPK3
Leptin Insulin Overlap WP3935	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	DGKZ
Platelet-mediated interactions with vascular and circulating cells WP4462	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	CCL2
Sulfation Biotransformation Reaction WP692	1/17	0.3492984738086775	1.0	0	0	2.357656489449487	2.4798502804764877	SULT1A1
Vitamin B12 Metabolism WP1533	2/50	0.35568043613445394	1.0	0	0	1.6032064128256514	1.6572707055198723	CCL2;MPO
TCA Cycle (aka Krebs or citric acid cycle) WP78	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	SUCLG2
TGF-B Signaling in Thyroid Cells for Epithelial-Mesenchymal Transition WP3859	1/18	0.36554726108427393	1.0	0	0	2.22667557336896	2.2408365683798293	MAPK3
One carbon metabolism and related pathways WP3940	2/52	0.37370679355392844	1.0	0	0	1.5415446277169724	1.5173173477586306	CHKB;CSAD
Cell Differentiation - Index expanded WP2023	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	KLF4
Serotonin Receptor 4/6/7 and NR3C Signaling WP734	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	MAPK3
Small Ligand GPCRs WP247	1/19	0.38139108902006696	1.0	0	0	2.1094821221390148	2.033392996431885	PTGDR
Allograft Rejection WP2328	3/89	0.3836457319085762	1.0	0	0	1.3510166400216161	1.2943222067258568	IL10;LRRK2;CXCL13
T-Cell antigen Receptor (TCR)  Signaling Pathway WP69	3/90	0.3904133844435715	1.0	0	0	1.3360053440213762	1.2565786788347324	CD4;WAS;MAPK3
IL-4 Signaling Pathway WP395	2/54	0.3915249643863088	1.0	0	0	1.4844503822459734	1.3919780295273776	HRH1;MAPK3
BMP Signaling Pathway in Eyelid Development WP3927	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	MAPK3
Hypertrophy Model WP516	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	IL1R1
Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732	1/20	0.3968400302739368	1.0	0	0	2.0040080160320644	1.8521483485228958	MAPK3
Amino Acid metabolism WP3925	3/91	0.3971624190671116	1.0	0	0	1.3213239666145478	1.220123718983501	P4HA2;ALDH1A1;HNMT
DNA IR-Double Strand Breaks (DSBs) and cellular response via ATM WP3959	2/55	0.4003486021478105	1.0	0	0	1.4574603752960467	1.3341878025796103	RASSF1;TP53BP1
Pathogenic Escherichia coli infection WP2272	2/55	0.4003486021478105	1.0	0	0	1.4574603752960467	1.3341878025796103	WAS;TLR5
G Protein Signaling Pathways WP35	3/93	0.4105981346365888	1.0	0	0	1.2929083974400413	1.1508698913002264	GNG4;AKAP7;GNG12
Glycerophospholipid Biosynthetic Pathway WP2533	1/21	0.41190390766271523	1.0	0	0	1.90857906288768	1.6928431924118923	CHKB
Nicotine Activity on Dopaminergic Neurons WP1602	1/21	0.41190390766271523	1.0	0	0	1.90857906288768	1.6928431924118923	CHRNA6
Angiopoietin Like Protein 8 Regulatory Pathway WP3915	4/132	0.4192144682364564	1.0	0	0	1.2145503127467057	1.0558968028761182	GSK3A;FBP1;MAP2K6;MAPK3
Preimplantation Embryo WP3527	2/58	0.4264465264050228	1.0	0	0	1.3820744938152165	1.1778982760344732	DLX2;KLF4
Methionine De Novo and Salvage Pathway WP3580	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	MSRA
NAD+ biosynthetic pathways WP3645	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	BST1
Regulation of Apoptosis by Parathyroid Hormone-related Protein WP3872	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	GSK3A
Vitamin D in inflammatory diseases WP4482	1/22	0.42659230012065946	1.0	0	0	1.8218254691200584	1.5520614365461916	MAP2K6
Kit receptor signaling pathway WP304	2/59	0.43501379097770626	1.0	0	0	1.3586495023946197	1.1309093373173045	BTK;MAPK3
MET in type 1 papillary renal cell carcinoma WP4205	2/59	0.43501379097770626	1.0	0	0	1.3586495023946197	1.1309093373173045	MET;MAPK3
B Cell Receptor Signaling Pathway WP23	3/97	0.43717752665197956	1.0	0	0	1.2395925872363285	1.0256586495480642	GSK3A;BTK;MAP2K6
Blood Clotting Cascade WP272	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	SERPINB2
Hippo-Yap signaling pathway WP4537	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	RASSF1
NRF2-ARE regulation WP4357	1/23	0.4409145486177336	1.0	0	0	1.7426156661148384	1.4270352698742312	SLC7A11
Angiogenesis WP1539	1/24	0.4548797623515939	1.0	0	0	1.67000668002672	1.3155012583860386	MMP9
Glycosylation and related congenital defects. WP4521	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	DOLK
Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	MAPK3
IL-7 Signaling Pathway WP205	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	MAPK3
MTHFR deficiency WP4288	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	HNMT
Signal Transduction of S1P Receptor WP26	1/25	0.4684968242387519	1.0	0	0	1.6032064128256514	1.2155927148684615	MAPK3
Endometrial cancer WP4155	2/63	0.4685698743106791	1.0	0	0	1.27238604192512	0.9645577423859204	MAPK3;GADD45G
PI3K-Akt Signaling Pathway WP4172	9/340	0.4759393525195222	1.0	0	0	1.0609454202522692	0.7877146754535862	PPP2CB;GNG4;ITGA2;SPP1;GNG12;MET;PGF;CREB5;MAPK3
EPO Receptor Signaling WP581	1/26	0.48177439669322825	1.0	0	0	1.5415446277169724	1.1257581796782758	MAPK3
Oncostatin M Signaling Pathway WP2374	2/65	0.4848972014536226	1.0	0	0	1.233235702173578	0.8926386511807349	CCL2;MAPK3
Brain-Derived Neurotrophic Factor (BDNF) signaling pathway WP2380	4/144	0.48528644823419126	1.0	0	0	1.11333778668448	0.8049609746973296	NCF1;SPP1;CAMK1;MAPK3
Folate Metabolism WP176	2/66	0.4929433227493972	1.0	0	0	1.2145503127467057	0.8591256155286086	CCL2;MPO
Human Thyroid Stimulating Hormone (TSH) signaling pathway WP2032	2/66	0.4929433227493972	1.0	0	0	1.2145503127467057	0.8591256155286086	MAPK3;MAP2K6
Canonical  and Non-canonical Notch signaling WP3845	1/27	0.49472092704616494	1.0	0	0	1.4844503822459734	1.0446989670368623	HEY1
Follicle Stimulating Hormone (FSH) signaling pathway WP2035	1/27	0.49472092704616494	1.0	0	0	1.4844503822459734	1.0446989670368623	MAPK3
Gastric Cancer Network 1 WP2361	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	CCNA1
PDGFR-beta pathway WP3972	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	MAPK3
Statin Pathway WP430	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	LRP1
T-Cell Receptor and Co-stimulatory Signaling WP2583	1/29	0.5196536067270527	1.0	0	0	1.3820744938152165	0.9046960545734432	GSK3A
Integrated Breast Cancer Pathway WP1984	4/151	0.5224173117304216	1.0	0	0	1.0617261012090407	0.6893666142650531	GSK3A;PKIA;TFPI;RPP38
Dopaminergic Neurogenesis WP2855	1/30	0.531655622454183	1.0	0	0	1.3360053440213762	0.8440338349505794	ALDH1A1
miRNA Regulation of DNA Damage Response WP1530	2/71	0.5319562504982418	1.0	0	0	1.1290186005814447	0.7126297992352149	CDC20B;GADD45G
VEGFA-VEGFR2 Signaling Pathway WP3888	6/236	0.5388838324233038	1.0	0	0	1.018987126795965	0.6299941464925066	NCF1;TNFRSF10C;CCL2;PGF;MAP2K6;MAPK3
Primary Focal Segmental Glomerulosclerosis FSGS WP2572	2/72	0.5395094657929208	1.0	0	0	1.11333778668448	0.6870351246335921	CR1;CTSL
IL17 signaling pathway WP2112	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	MAPK3
Tumor suppressor activity of SMARCB1 WP4204	1/31	0.5433583388350804	1.0	0	0	1.2929083974400413	0.7886563481965001	SMARCD3
Chromosomal and microsatellite instability in colorectal cancer  WP4216	2/73	0.5469780355586858	1.0	0	0	1.0980865841271583	0.6625268418898659	MAPK3;GADD45G
Focal Adhesion WP306	5/198	0.5518624950906427	1.0	0	0	1.0121252606222546	0.6016643052094425	ITGA2;SPP1;MET;PGF;MAPK3
Arrhythmogenic Right Ventricular Cardiomyopathy WP2118	2/74	0.5543614743664991	1.0	0	0	1.0832475762335483	0.6390492598190445	ITGA2;CACNA2D3
Constitutive Androstane Receptor Pathway WP2875	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	SULT1A1
Development and heterogeneity of the ILC family WP3893	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	HNF1A
White fat cell differentiation WP4149	1/32	0.5547692049322223	1.0	0	0	1.25250501002004	0.7379798330323151	KLF4
Alpha 6 Beta 4 signaling pathway WP244	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	MAPK3
Oxidative Stress WP408	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	CYP1A1
Resistin as a regulator of inflammation WP4481	1/33	0.5658954848618294	1.0	0	0	1.2145503127467057	0.6914992087824988	MAPK3
Leptin signaling pathway WP2034	2/76	0.568871397371907	1.0	0	0	1.0547410610695074	0.5949803665907504	GSK3A;MAPK3
Prolactin Signaling Pathway WP2037	2/76	0.568871397371907	1.0	0	0	1.0547410610695074	0.5949803665907504	NEK3;MAPK3
Fatty Acid Beta Oxidation WP143	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	CHKB
p38 MAPK Signaling Pathway WP400	1/34	0.5767442622659661	1.0	0	0	1.1788282447247436	0.6487755869007844	MAP2K6
Cell Cycle WP179	3/120	0.5789471346397347	1.0	0	0	1.0020040080160322	0.5476393889501465	CDKN2D;CCNA1;GADD45G
Fibrin Complement Receptor 3 Signaling Pathway WP4136	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	CCL2
The effect of progerin on the involved genes in Hutchinson-Gilford Progeria Syndrome WP4320	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	MTA2
Type II interferon signaling (IFNG) WP619	1/37	0.607693802400194	1.0	0	0	1.0832475762335483	0.5395484356233516	SPI1
Amyotrophic lateral sclerosis (ALS) WP2447	1/38	0.617499951558055	1.0	0	0	1.0547410610695074	0.5084656565008984	MAP2K6
G13 Signaling Pathway WP524	1/39	0.627061462527919	1.0	0	0	1.0276964184779815	0.4796369321136311	WAS
PDGF Pathway WP2526	1/39	0.627061462527919	1.0	0	0	1.0276964184779815	0.4796369321136311	MAPK3
Pyrimidine metabolism WP4022	2/85	0.629891951486803	1.0	0	0	0.9430625957797949	0.4358901142348933	CDA;DPYD
Adipogenesis WP236	3/130	0.6331506778900918	1.0	0	0	0.9249267766301835	0.4227348673563011	EPAS1;ID3;HNF1A
Selenium Micronutrient Network WP15	2/86	0.6362406061926168	1.0	0	0	0.9320967516428205	0.42147408823246774	CCL2;MPO
ATM Signaling Pathway WP2516	1/40	0.6363844264214737	1.0	0	0	1.0020040080160322	0.4528581705268795	TP53BP1
Hair Follicle Development: Cytodifferentiation (Part 3 of 3) WP2840	2/87	0.6425036413513994	1.0	0	0	0.921382995876811	0.4076039847564804	WNT5A;PHLDA1
Retinoblastoma Gene in Cancer WP2446	2/87	0.6425036413513994	1.0	0	0	0.921382995876811	0.4076039847564804	RABIF;RPA3
TGF-beta Signaling Pathway WP366	3/132	0.6433911876346755	1.0	0	0	0.9109127345600292	0.4017146664500507	ITGA2;MET;MAP2K6
Common Pathways Underlying Drug Addiction WP2636	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	MAPK3
DNA Replication WP466	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	RPA3
IL-2 Signaling Pathway WP49	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	MAPK3
Metabolic reprogramming in colon cancer WP4290	1/42	0.6543383244988259	1.0	0	0	0.95428953144384	0.4047435304314916	SUCLG2
Cytoplasmic Ribosomal Proteins WP477	2/89	0.6547741362150727	1.0	0	0	0.9006777600144108	0.38140544731754533	RPL36A;RPS10
Pancreatic adenocarcinoma pathway WP4263	2/89	0.6547741362150727	1.0	0	0	0.9006777600144108	0.38140544731754533	MAPK3;GADD45G
IL-6 signaling pathway WP364	1/43	0.6629806990679474	1.0	0	0	0.9320967516428205	0.3831005273164136	MAPK3
ErbB Signaling Pathway WP673	2/91	0.6667063671398114	1.0	0	0	0.8808826444096985	0.35711472102140146	NRG1;MAPK3
Heart Development WP1591	1/44	0.6714074145685438	1.0	0	0	0.9109127345600292	0.3628886418772273	HEY1
Ectoderm Differentiation WP2858	3/138	0.6728926011406288	1.0	0	0	0.8713078330574192	0.3451856271931882	BCAS3;CCL2;SNCA
Corticotropin-releasing hormone signaling pathway WP2355	2/93	0.6783038044085001	1.0	0	0	0.8619389316266943	0.3345702176875032	ARRB1;MAPK3
ATM Signaling Network in Development and Disease  WP3878	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	TP53BP1
Glycolysis and Gluconeogenesis WP534	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	FBP1
Notch Signaling WP268	1/45	0.6796238418937326	1.0	0	0	0.8906702293475841	0.3439909218923916	RFNG
Selenium Metabolism and Selenoproteins WP28	1/46	0.6876352184737552	1.0	0	0	0.8713078330574192	0.3263019842853477	CREM
Exercise-induced Circadian Regulation WP410	1/48	0.70306312169229	1.0	0	0	0.83500334001336	0.29417885952429185	PPP2CB
IL-3 Signaling Pathway WP286	1/49	0.7104894851601173	1.0	0	0	0.8179624555232914	0.27958049222211656	MAPK3
Photodynamic therapy-induced AP-1 survival signaling. WP3611	1/50	0.7177304776127647	1.0	0	0	0.8016032064128257	0.26586064911887247	MAP2K6
Synaptic signaling pathways associated with autism spectrum disorder WP4539	1/50	0.7177304776127647	1.0	0	0	0.8016032064128257	0.26586064911887247	MAPK3
Integrin-mediated Cell Adhesion WP185	2/101	0.7214306590779099	1.0	0	0	0.7936665410027977	0.2591472148263827	ITGA2;MAP2K6
Wnt Signaling Pathway WP363	1/52	0.7316747071553329	1.0	0	0	0.7707723138584862	0.2408041104693983	GSK3A
Apoptosis-related network due to altered Notch3 in ovarian cancer WP2864	1/53	0.7383868385846662	1.0	0	0	0.7562294400120997	0.22935487593120754	NRG1
Cardiac Progenitor Differentiation WP2406	1/53	0.7383868385846662	1.0	0	0	0.7562294400120997	0.22935487593120754	NRG1
Senescence and Autophagy in Cancer WP615	2/105	0.7411058353222701	1.0	0	0	0.7634316251550721	0.22873315101790864	SERPINB2;GSN
Interferon type I signaling pathways WP585	1/54	0.7449313935863037	1.0	0	0	0.7422251911229867	0.21855797074812172	MAP2K6
Nonalcoholic fatty liver disease WP4396	3/155	0.746603678064511	1.0	0	0	0.7757450384640249	0.22668882494900022	GSK3A;NDUFB1;CCL2
Thermogenesis WP4321	2/108	0.7550724738628684	1.0	0	0	0.7422251911229867	0.20852189005320892	SMARCD3;CREB5
Mitochondrial complex I assembly model OXPHOS system WP4324	1/56	0.7575343725314059	1.0	0	0	0.71571714858288	0.1987448943236483	NDUFB1
Insulin Signaling WP481	3/160	0.7655836255390477	1.0	0	0	0.751503006012024	0.20073909831277228	GSK3A;MAP2K6;MAPK3
Oxidative phosphorylation WP623	1/60	0.7809063226585379	1.0	0	0	0.6680026720106881	0.16519711537479384	NDUFB1
Notch Signaling Pathway WP61	1/61	0.7863891198039291	1.0	0	0	0.657051808535103	0.15789187929471432	HEY1
Oxidation by Cytochrome P450 WP43	1/61	0.7863891198039291	1.0	0	0	0.657051808535103	0.15789187929471432	CYP1A1
Hippo-Merlin Signaling Dysregulation WP4541	2/120	0.8046053057444223	1.0	0	0	0.6680026720106881	0.14522606895436108	ITGA2;MET
DNA Damage Response WP707	1/68	0.8211197204007441	1.0	0	0	0.5894141223623718	0.11616548243816698	GADD45G
RAC1/PAK1/p38/MMP2 Pathway WP3303	1/68	0.8211197204007441	1.0	0	0	0.5894141223623718	0.11616548243816698	MAPK3
AMP-activated Protein Kinase (AMPK) Signaling WP1403	1/69	0.8255979685294595	1.0	0	0	0.5808718887049461	0.11132255517230018	CCNA1
Sterol Regulatory Element-Binding Proteins (SREBP) signalling WP1982	1/69	0.8255979685294595	1.0	0	0	0.5808718887049461	0.11132255517230018	GSK3A
Peptide GPCRs WP24	1/74	0.8463655642939709	1.0	0	0	0.5416237881167741	0.09034496214788214	CCR4
DNA IR-damage and cellular response via ATR WP4016	1/80	0.8680544760727233	1.0	0	0	0.5010020040080161	0.0708921872939356	TP53BP1
Apoptosis WP254	1/84	0.880787733145988	1.0	0	0	0.47714476572192	0.060568098395180583	DFFB
Pathways in clear cell renal cell carcinoma WP4018	1/85	0.8837745785440082	1.0	0	0	0.47153129788989745	0.0582592245714919	CAMK1
Mesodermal Commitment Pathway WP2857	2/147	0.8848428940528873	1.0	0	0	0.5453083036821943	0.06671583743110317	KLF4;TRERF1
GPCRs, Other WP117	1/91	0.9001907994855396	1.0	0	0	0.4404413222048493	0.04631176141212195	P2RY13
Pathways Regulating Hippo Signaling WP4540	1/98	0.9164410361476484	1.0	0	0	0.4089812277616457	0.0356866997963363	MET
Electron Transport Chain (OXPHOS system in mitochondria) WP111	1/103	0.9264047749877665	1.0	0	0	0.3891277701033134	0.02974649019550871	NDUFB1
DNA Damage Response (only ATM dependent) WP710	1/110	0.9383936227211765	1.0	0	0	0.36436509382401167	0.02316843781112707	WNT5A
mRNA Processing WP411	1/126	0.9589784016902992	1.0	0	0	0.31809651048128	0.01332402139252831	CLASRP
Endoderm Differentiation WP2853	1/141	0.9719901343266996	1.0	0	0	0.28425645617476086	0.008075619165382937	TRERF1
Ciliary landscape WP4352	2/216	0.9727322380282003	1.0	0	0	0.37111259556149334	0.01025993721834995	ERF;CDH23
